Yunnan Botanee Bio-Technology Group Co.LTD (SHE: 300957)
China
· Delayed Price · Currency is CNY 49.76
-0.96 (-1.89%)
Nov 15, 2024, 3:04 PM CST
Yunnan Botanee Bio-Technology Group Co.LTD Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Operating Revenue | 6,088 | 5,502 | 4,998 | 4,008 | 2,621 | 1,934 | Upgrade
|
| Other Revenue | 20.55 | 20.55 | 16.12 | 14.63 | 15.91 | 9.3 | Upgrade
|
| Revenue | 6,108 | 5,522 | 5,014 | 4,022 | 2,636 | 1,944 | Upgrade
|
| Revenue Growth (YoY) | 10.06% | 10.14% | 24.65% | 52.57% | 35.64% | 56.69% | Upgrade
|
| Cost of Revenue | 1,708 | 1,462 | 1,262 | 977.08 | 635.17 | 397.04 | Upgrade
|
| Gross Profit | 4,401 | 4,061 | 3,752 | 3,045 | 2,001 | 1,547 | Upgrade
|
| Selling, General & Admin | 3,524 | 3,023 | 2,391 | 1,926 | 1,276 | 983 | Upgrade
|
| Research & Development | 316.62 | 298.82 | 254.7 | 113.22 | 63.44 | 51.26 | Upgrade
|
| Other Operating Expenses | 115.39 | 47.45 | 54.71 | 52.12 | 10.77 | 34.94 | Upgrade
|
| Operating Expenses | 3,967 | 3,382 | 2,700 | 2,097 | 1,355 | 1,070 | Upgrade
|
| Operating Income | 433.97 | 678.46 | 1,052 | 948.45 | 645.86 | 476.34 | Upgrade
|
| Interest Expense | -13.2 | -4.97 | -4.75 | -4.19 | -1.33 | -0.03 | Upgrade
|
| Interest & Investment Income | 90.25 | 92.91 | 100.88 | 33.62 | 5.7 | 1.78 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.72 | -0.72 | 0.03 | -0 | - | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.82 | - | -1.72 | -0.53 | -2.21 | -0.16 | Upgrade
|
| EBT Excluding Unusual Items | 517.11 | 765.68 | 1,147 | 977.35 | 648.01 | 477.94 | Upgrade
|
| Gain (Loss) on Sale of Investments | 24.15 | -17.24 | -5.52 | 10.8 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.13 | 0.69 | -0.03 | 0.52 | -0.17 | -0.1 | Upgrade
|
| Asset Writedown | 0.34 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | 162.72 | 119.69 | 72.75 | 29.21 | - | 24.4 | Upgrade
|
| Pretax Income | 703.21 | 868.82 | 1,214 | 1,018 | 647.84 | 502.24 | Upgrade
|
| Income Tax Expense | 104.56 | 109.61 | 163.33 | 153.81 | 104.08 | 89.18 | Upgrade
|
| Earnings From Continuing Operations | 598.65 | 759.21 | 1,051 | 864.06 | 543.75 | 413.06 | Upgrade
|
| Minority Interest in Earnings | -6.27 | -2.42 | 0.8 | -1.14 | -0.25 | -1.12 | Upgrade
|
| Net Income | 592.37 | 756.8 | 1,051 | 862.92 | 543.51 | 411.95 | Upgrade
|
| Net Income to Common | 592.37 | 756.8 | 1,051 | 862.92 | 543.51 | 411.95 | Upgrade
|
| Net Income Growth | -46.79% | -28.02% | 21.83% | 58.77% | 31.94% | 58.12% | Upgrade
|
| Shares Outstanding (Basic) | 420 | 423 | 424 | 407 | 360 | 361 | Upgrade
|
| Shares Outstanding (Diluted) | 421 | 423 | 424 | 407 | 360 | 361 | Upgrade
|
| Shares Change (YoY) | -1.06% | -0.27% | 4.15% | 13.09% | -0.39% | - | Upgrade
|
| EPS (Basic) | 1.41 | 1.79 | 2.48 | 2.12 | 1.51 | 1.14 | Upgrade
|
| EPS (Diluted) | 1.41 | 1.79 | 2.48 | 2.12 | 1.51 | 1.14 | Upgrade
|
| EPS Growth | -46.22% | -27.82% | 16.98% | 40.40% | 32.46% | - | Upgrade
|
| Free Cash Flow | 116.93 | 336.16 | 416.02 | 882.04 | 341.57 | 453.91 | Upgrade
|
| Free Cash Flow Per Share | 0.28 | 0.80 | 0.98 | 2.17 | 0.95 | 1.26 | Upgrade
|
| Dividend Per Share | 0.600 | 0.600 | 0.800 | 0.600 | 0.450 | 0.280 | Upgrade
|
| Dividend Growth | -24.94% | -24.94% | 33.33% | 33.33% | 60.71% | - | Upgrade
|
| Gross Margin | 72.04% | 73.53% | 74.83% | 75.71% | 75.91% | 79.57% | Upgrade
|
| Operating Margin | 7.10% | 12.29% | 20.99% | 23.58% | 24.50% | 24.51% | Upgrade
|
| Profit Margin | 9.70% | 13.70% | 20.97% | 21.45% | 20.61% | 21.19% | Upgrade
|
| Free Cash Flow Margin | 1.91% | 6.09% | 8.30% | 21.93% | 12.96% | 23.35% | Upgrade
|
| EBITDA | 493.32 | 737.33 | 1,110 | 968.11 | 659.61 | 488.11 | Upgrade
|
| EBITDA Margin | 8.08% | 13.35% | 22.15% | 24.07% | 25.02% | 25.11% | Upgrade
|
| D&A For EBITDA | 59.35 | 58.87 | 58.23 | 19.66 | 13.74 | 11.76 | Upgrade
|
| EBIT | 433.97 | 678.46 | 1,052 | 948.45 | 645.86 | 476.34 | Upgrade
|
| EBIT Margin | 7.10% | 12.29% | 20.99% | 23.58% | 24.50% | 24.51% | Upgrade
|
| Effective Tax Rate | 14.87% | 12.62% | 13.46% | 15.11% | 16.07% | 17.76% | Upgrade
|
| Revenue as Reported | 6,108 | 5,522 | 5,014 | 4,022 | 2,636 | 1,944 | Upgrade
|
| Advertising Expenses | - | 1,922 | 1,534 | 1,249 | 811.84 | 487.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.